Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin

death receptors

  • You have access
    Ursolic Acid Promotes the Sensitization of rhTRAIL-resistant Triple-negative Breast Cancer
    JASMINE M. MANOUCHEHRI and MICHAEL KALAFATIS
    Anticancer Research December 2018, 38 (12) 6789-6795; DOI: https://doi.org/10.21873/anticanres.13050
  • You have access
    Sensitization of rhTRAIL-resistant Triple-negative Breast Carcinoma Through Silibinin Co-Treatment
    JASMINE M. MANOUCHEHRI and MICHAEL KALAFATIS
    Anticancer Research December 2017, 37 (12) 6593-6599;
  • You have access
    Histone Deacetylase-1-mediated Suppression of FAS in Chemoresistant Ovarian Cancer Cells
    ERCAN CACAN
    Anticancer Research June 2016, 36 (6) 2819-2826;
  • You have access
    Death Receptor Expression on Blasts in AML Is Associated with Unfavorable Prognosis
    JOERG UWE SCHMOHL, TINA NUEBLING, JULIA WILD, JOHANNES JUNG, TANJA KROELL, LOTHAR KANZ, HELMUT R. SALIH and HELGA SCHMETZER
    Anticancer Research July 2015, 35 (7) 4043-4052;
  • You have access
    Combination Effect of Equol and TRAIL against Human Cervical Cancer Cells
    EUN YOUNG KIM and AN KEUN KIM
    Anticancer Research March 2013, 33 (3) 903-912;
Anticancer Research

© 2026 Anticancer Research

Powered by HighWire